RBI:VIERaiffeisen Bank International AG Analysis
Data as of 2026-03-11 - not real-time
€38.96
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Raiffeisen Bank International trades around €38.96, comfortably above its 20‑day SMA of €40.75 yet below the 50‑day SMA, reinforcing a bullish bias reflected in the computed trend direction. The stock sits near the midpoint of its technical corridor, with a support level at €34.32 and resistance at €44.36, while volume is on an upward trajectory, suggesting continued buying interest. Momentum indicators are mixed: the RSI at 44.6 points to neutral pressure, whereas the MACD histogram remains in bearish territory, hinting at short‑term caution. Fundamentally, the bank posts a solid operating margin of 49.7% and a profit margin of 15.3%, with revenue growing modestly at 4% YoY, and a dividend yield of 2.79% backed by a conservative payout ratio of 28.8%. Valuation metrics are attractive – a trailing P/E of 10.2 versus an industry average of 17.1 and a price‑to‑book of 0.66 signal the stock is priced below peers, while the DCF model implies a modest upside of roughly 5%.
The balance sheet is bolstered by €42.5 bn in cash against €28.4 bn of debt, and a low computed beta of 0.54 points to limited market volatility relative to the broader index. However, the bank’s heavy exposure to Central and Eastern Europe, including markets with heightened geopolitical and regulatory uncertainty, adds a layer of geographic and compliance risk. Overall, the combination of a respectable dividend, undervalued multiples, and a stable earnings profile supports a cautiously optimistic stance, tempered by sector‑specific headwinds.
The balance sheet is bolstered by €42.5 bn in cash against €28.4 bn of debt, and a low computed beta of 0.54 points to limited market volatility relative to the broader index. However, the bank’s heavy exposure to Central and Eastern Europe, including markets with heightened geopolitical and regulatory uncertainty, adds a layer of geographic and compliance risk. Overall, the combination of a respectable dividend, undervalued multiples, and a stable earnings profile supports a cautiously optimistic stance, tempered by sector‑specific headwinds.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price hovering between support and resistance with limited upside
- Bearish MACD signal offset by overall bullish trend
- Increasing trading volume indicating continued market participation
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Undervalued relative to sector peers (P/E 10.2 vs 17.1 industry avg)
- Attractive dividend yield and low payout ratio
- Modest upside potential from DCF and technical positioning
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Strong cash generation and low leverage supporting dividend sustainability
- Low beta suggesting reduced market volatility over time
- Diversified regional footprint offering growth opportunities as Eastern European economies stabilize
Key Metrics & Analysis
Financial Health
Revenue Growth4.00%
Profit Margin15.26%
P/E Ratio10.2
ROE7.57%
ROA0.79%
P/B Ratio0.7
Op. Cash Flow€9.1B
Industry P/E17.1
Technical Analysis
TrendBullish
RSI44.6
Support€34.32
Resistance€44.36
MA 20€40.75
MA 50€40.18
MA 200€32.17
MACDBearish
VolumeIncreasing
Fear & Greed Index77.52
Valuation
Fair Value€362.36
Target Price€40.85
Upside/Downside4.84%
GradeFair
TypeBlend
Dividend Yield2.79%
Risk Assessment
Beta0.54
Volatility41.89%
Sector RiskMedium
Reg. RiskHigh
Geo RiskHigh
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.